Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nerve Sheath Neoplasms × pirfenidone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibroma, Plexiform 2 Squamous Cell Carcinoma of Head and Neck 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Nerve Sheath Neoplasms 1 Myofibroma 1 Lymphedema 1 Lung Neoplasms 1 Leiomyoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Acute Lung Injury 1

Interventions

tazemetostat 1 pirfenidone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00076102 2018-04-23

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

36 enrolled 13 charts

Neurofibromatosis 1, Nerve Sheath Neoplasms, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡